Screening for Primary Aldosteronism by Mass Spectrometry Versus Immunoassay Measurements of Aldosterone: A Prospective Within-Patient Study

Sybille Fuld; Georgiana Constantinescu; Christina Pamporaki; Mirko Peitzsch; Manuel Schulze; Jun Yang; Lisa Müller; Aleksander Prejbisz; Andrzej Januszewicz; Hanna Remde; Lydia Kürzinger; Ulrich Dischinger; Matthias Ernst; Sven Gruber; Martín Reincke; Felix Beuschlein; Jacques W.M. Lenders; Graeme Eisenhofer

doi:10.1093/jalm/jfae017

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Measurements of aldosterone by mass spectrometry are more accurate and less prone to interferences than immunoassay measurements, and may produce a more accurate aldosterone:renin ratio (ARR) when screening for primary aldosteronism (PA).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Fuld et al. (2024) studied this question.

synapsesocial.com/papers/68e721f4b6db64358769b1b7 https://doi.org/10.1093/jalm/jfae017

View Full Paper

Ask AI

Bookmark

Share

Screening for Primary Aldosteronism by Mass Spectrometry Versus Immunoassay Measurements of Aldosterone: A Prospective Within-Patient Study

Ask about this paper

Abstract

Discussion

Cite This Study

Screening for Primary Aldosteronism by Mass Spectrometry Versus Immunoassay Measurements of Aldosterone: A Prospective Within-Patient Study

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading